Kelley Kenneth J 4
4 · HALOZYME THERAPEUTICS, INC. · Filed Nov 27, 2020
Insider Transaction Report
Form 4
Kelley Kenneth J
Director
Transactions
- Sale
Common Stock
2020-11-27$41.25/sh−10,000$412,500→ 266,711 total - Sale
Common Stock
2020-11-25$41.50/sh−9,671$401,350→ 276,711 total
Footnotes (1)
- [F1]Represents a weighted average sales price per share. These shares were sold at prices ranging from $41.50 to $41.5102. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.